Van Gool, S.W.; Makalowski, J.; Van de Vliet, P.; Van Gool, S.; Sprenger, T.; Schirrmacher, V.; Stuecker, W.
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience. Cancers 2023, 15, 1194.
https://doi.org/10.3390/cancers15041194
AMA Style
Van Gool SW, Makalowski J, Van de Vliet P, Van Gool S, Sprenger T, Schirrmacher V, Stuecker W.
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience. Cancers. 2023; 15(4):1194.
https://doi.org/10.3390/cancers15041194
Chicago/Turabian Style
Van Gool, Stefaan W., Jennifer Makalowski, Peter Van de Vliet, Stefanie Van Gool, Tobias Sprenger, Volker Schirrmacher, and Wilfried Stuecker.
2023. "Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience" Cancers 15, no. 4: 1194.
https://doi.org/10.3390/cancers15041194
APA Style
Van Gool, S. W., Makalowski, J., Van de Vliet, P., Van Gool, S., Sprenger, T., Schirrmacher, V., & Stuecker, W.
(2023). Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience. Cancers, 15(4), 1194.
https://doi.org/10.3390/cancers15041194